Statement Of Financial Position [Abstract]

Xbrane Biopharma - Filing #689992

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	34 830 SEK	—	—	—	—	30 622 SEK	—	—	—	—	—	—	—	—	—
Right-of-use assets	36 220 SEK	—	—	—	—	43 180 SEK	—	—	—	—	—	—	—	—	—
Goodwill	– SEK	—	—	—	—	– SEK	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	101 995 SEK	—	—	—	—	49 672 SEK	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	193 994 SEK	—	—	—	—	295 180 SEK	—	—	—	—	243 139 SEK	—	—	—	—
Assets	690 515 SEK	—	—	—	—	688 427 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	6 166 SEK	—	—	—	—	5 614 SEK	—	—	—	—	—	—	—	—	—
Retained earnings	885 827 SEK	—	—	—	—	713 313 SEK	—	—	—	—	—	—	—	—	—
Share premium	1 294 227 SEK	—	—	—	—	1 134 276 SEK	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	424 888 SEK	—	—	—	—	431 741 SEK	—	—	—	—	—	—	—	—	—
Non-controlling interests	– SEK	—	—	—	—	– SEK	—	—	—	—	—	—	—	—	—
Equity	424 888 SEK	1 294 227 SEK	885 827 SEK	6 166 SEK	10 322 SEK	431 741 SEK	713 313 SEK	1 134 276 SEK	5 165 SEK	5 614 SEK	257 709 SEK	4 977 SEK	524 938 SEK	3 945 SEK	773 724 SEK
Liabilities [abstract]
Liabilities included in disposal groups classified as held for sale	937,000 SEK	—	—	—	—	1 257 SEK	—	—	—	—	—	—	—	—	—
Liabilities	265 626 SEK	—	—	—	—	256 686 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities	690 515 SEK	—	—	—	—	688 427 SEK	—	—	—	—	—	—	—	—	—